Can fluorodihydroxyphenylalanine PET replace somatostatin receptor scintigraphy in patients with digestive endocrine tumors? - Montravers,F.; Grahek,D.; Kerrou,K.; Ruszniewski,P.; de Beco,V.; Aide,N.; Gutman,F.; Grange,J.D.; Lotz,J.P.; Talbot,J.N. (J Nucl Med, 2006)